Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (38)
Aparajita Ghosh, Ambati Himaja, Swati Biswas, Onkar Kulkarni & Balaram Ghosh. (2023) Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer. Molecular Pharmaceutics 20:12, pages 5981-6009.
Crossref
Crossref
Xiaobo Wang, Lihua Yuan, Bo Lu, Dongjun Lin & Xiaojun Xu. (2023) Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle. Experimental and Therapeutic Medicine 26:6.
Crossref
Crossref
Ismail Al-Janabi. (2023) Therapeutic Targeting of the Regulators of Cancer Epigenomes. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 5, pages 1-13.
Crossref
Crossref
Sharina C. Macapagal & N. Nora Bennani. (2023) Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet?. Blood Reviews 60, pages 101071.
Crossref
Crossref
Shi-Yi Lyu, Wang Xiao, Guang-Zu Cui, Cheng Yu, Huan Liu, Min Lyu, Qian-Ya Kuang, En-Hua Xiao & Yong-Heng Luo. (2023) Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis. Frontiers in Genetics 14.
Crossref
Crossref
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, Soohyun Choe, Misung Park, Woori Kwak & Hyunho Yoon. (2023) Epigenetic Regulation in Breast Cancer: Insights on Epidrugs. Epigenomes 7:1, pages 6.
Crossref
Crossref
Pedro Mikael da Silva Costa, Sarah Leyenne Alves Sales, Daniel Pascoalino Pinheiro, Larissa Queiroz Pontes, Sarah Sant’Anna Maranhão, Claudia do Ó. Pessoa, Gilvan Pessoa Furtado & Cristiana Libardi Miranda Furtado. (2023) Epigenetic reprogramming in cancer: From diagnosis to treatment. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Leonardo Castro‑Muñoz, Elenaé Ulloa, Cecilia Sahlgren, Marcela Lizano, Erick De La Cruz-Hernández & Adriana Contreras‑Paredes. (2023) Modulating epigenetic modifications for cancer therapy (Review). Oncology Reports 49:3.
Crossref
Crossref
Yangfu Jiang, Hongying Zhang, Jiao Wang, Jinzhu Chen, Zeyu Guo, Yongliang Liu & Hui Hua. (2023) Exploiting RIG-I-like receptor pathway for cancer immunotherapy. Journal of Hematology & Oncology 16:1.
Crossref
Crossref
Amit Kumar, Luni Emdad, Paul B. Fisher & Swadesh K. Das. 2023. Epigenetic Regulation of Cancer in Response to Chemotherapy. Epigenetic Regulation of Cancer in Response to Chemotherapy
73
161
.
Vinit Singh Baghel, Sapnita Shinde, Vibha Sinha, Vineeta Dixit, Atul Kumar Tiwari, Saurabh Saxena, Naveen Kumar Vishvakarma, Dhananjay Shukla & Prashant Bhatt. 2023. Transcription and Translation in Health and Disease. Transcription and Translation in Health and Disease
287
324
.
Saumya Srivastava & Anjana Pandey. 2023. Oncology: Genomics, Precision Medicine and Therapeutic Targets. Oncology: Genomics, Precision Medicine and Therapeutic Targets
1
24
.
Aysun Adan. 2023.
Sai‐Juan Chen, Xiao‐Jing Yan, Guang‐Biao Zhou & Zhu Chen. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
19
.
Stephen B. Baylin. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
13
.
Marion Turpin & Gilles Salbert. (2022) 5-methylcytosine turnover: Mechanisms and therapeutic implications in cancer. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Victor M. Del Castillo Falconi, Karla Torres-Arciga, Genaro Matus-Ortega, José Díaz-Chávez & Luis A. Herrera. (2022) DNA Methyltransferases: From Evolution to Clinical Applications. International Journal of Molecular Sciences 23:16, pages 8994.
Crossref
Crossref
Libo Xu, Jinghua Zhang, Jicheng Sun, Kunlin Hou, Chenxin Yang, Ying Guo, Xiaorui Liu, Dhan V. Kalvakolanu, Ling Zhang & Baofeng Guo. (2022) Epigenetic regulation of cancer stem cells: Shedding light on the refractory/relapsed cancers. Biochemical Pharmacology 202, pages 115110.
Crossref
Crossref
Shohre Karimi Kelaye, Fatemeh Najafi, Bahareh Kazemi, Zahra Foruzandeh, Farhad Seif, Saeed Solali & Mohammad-Reza Alivand. (2022) The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML. Clinical and Translational Oncology 24:7, pages 1250-1261.
Crossref
Crossref
Jonathan Wong, Emily Gruber, Belinda Maher, Mark Waltham, Zahra Sabouri-Thompson, Ian Jong, Quinton Luong, Sidney Levy, Beena Kumar, Daniella Brasacchio, Wendy Jia, Joan So, Hugh Skinner, Alexander Lewis, Simon J. Hogg, Stephin Vervoort, Carmen DiCorleto, Micheleine Uhe, Jeanette Gamgee, Stephen Opat, Gareth P. Gregory, Galina Polekhina, John Reynolds, Eliza A. Hawkes, Gajan Kailainathan, Robin Gasiorowski, Lev M. Kats & Jake Shortt. (2022) Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. Leukemia 36:6, pages 1654-1665.
Crossref
Crossref
Ji Xiao, Ping Liu, Yiliang Wang, Yexuan Zhu, Qiongzhen Zeng, Xiao Hu, Zhe Ren & Yifei Wang. (2022) A Novel Cognition of Decitabine: Insights into Immunomodulation and Antiviral Effects. Molecules 27:6, pages 1973.
Crossref
Crossref
Marton Siklos & Stefan Kubicek. (2021)
T
herapeutic targeting of chromatin: status and opportunities
. The FEBS Journal 289:5, pages 1276-1301.
Crossref
Crossref
Shengrui Feng & Daniel D. De Carvalho. (2021) Clinical advances in targeting epigenetics for cancer therapy. The FEBS Journal 289:5, pages 1214-1239.
Crossref
Crossref
Saran Chattopadhyaya & Somnath Ghosal. (2022) DNA methylation: a saga of genome maintenance in hematological perspective. Human Cell 35:2, pages 448-461.
Crossref
Crossref
香会 杨. (2022) Research Progress of Epigenetic Therapy in Acute Myeloid Leukemia. Advances in Clinical Medicine 12:08, pages 8001-8007.
Crossref
Crossref
Richard A. Stein & Abhi N. Deverakonda. 2023. Cancer Research: An Interdisciplinary Approach. Cancer Research: An Interdisciplinary Approach
183
240
.
Chunhong Hu, Xiaohan Liu, Yue Zeng, Junqi Liu & Fang Wu. (2021) DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clinical Epigenetics 13:1.
Crossref
Crossref
Christina-Nefeli Kontandreopoulou, Panagiotis T. Diamantopoulos, Despina Tiblalexi, Nefeli Giannakopoulou & Nora-Athina Viniou. (2021) PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. Blood Advances 5:22, pages 4794-4805.
Crossref
Crossref
Wenjing Xiao, Qiaodan Zhou, Xudong Wen, Rui Wang, Ruijie Liu, Tingting Wang, Jianyou Shi, Yonghe Hu & Jun Hou. (2021) Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy. Frontiers in Pharmacology 12.
Crossref
Crossref
Vincent G. Sorrentino, Srijan Thota, Edward A. Gonzalez, Pranela Rameshwar, Victor T. Chang & Jean-Pierre Etchegaray. (2021) Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia. Pharmaceuticals 14:7, pages 641.
Crossref
Crossref
Yi Zhang, Deqin Rong, Bingbing Li & Yuanxiang Wang. (2021) Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors. Journal of Medicinal Chemistry 64:12, pages 7900-7925.
Crossref
Crossref
Congwang Zhang, Lijun Li, Yipeng Zhang & Changchun Zeng. (2021) Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment. Frontiers in Oncology 11.
Crossref
Crossref
Milad Baroud, Elise Lepeltier, Sylvain Thepot, Yolla El-Makhour & Olivier Duval. (2021) The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery. Nanoscale Advances 3:8, pages 2157-2179.
Crossref
Crossref
Д.А. Храброва, М.Г. Якубовская & E.C. Громова. (2021) Мутации в ДНК-метилтрансферазе DNMT3A при остром миелоидном лейкозе. Биохимия 86:3, pages 360-373.
Crossref
Crossref
Dariya A. Khrabrova, Marianna G. Yakubovskaya & Elizaveta S. Gromova. (2021) AML-Associated Mutations in DNA Methyltransferase DNMT3A. Biochemistry (Moscow) 86:3, pages 307-318.
Crossref
Crossref
Eunyoung Lee, Youngil Koh, Junshik Hong, Hyeon-Seok Eom & Sung-Soo Yoon. (2021) Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies. Journal of Korean Medical Science 36:13.
Crossref
Crossref
Costantine Albany, Zeeshan Fazal, Ratnakar Singh, Emmanuel Bikorimana, Nabil Adra, Nasser H. Hanna, Lawrence H. Einhorn, Susan M. Perkins, George E. Sandusky, Brock C. Christensen, Harold Keer, Fang Fang, Kenneth P. Nephew & Michael J. Spinella. (2020) A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer. Cancer Medicine 10:1, pages 156-163.
Crossref
Crossref
Klara Cervena, Anna Siskova, Tomas Buchler, Pavel Vodicka & Veronika Vymetalkova. (2020) Methylation-Based Therapies for Colorectal Cancer. Cells 9:6, pages 1540.
Crossref
Crossref